Discovery Medicine

SCI SCIE

国际简称：DISCOV MED 参考译名：发现医学

主要研究方向：MEDICINE, RESEARCH & EXPERIMENTAL 非预警期刊审稿周期：较慢,6-12周

《发现医学》(Discovery Medicine)是一本由Timonium, MD : Discovery Medicine出版的以MEDICINE, RESEARCH & EXPERIMENTAL为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q2 JCR分区
247 年发文量
3.2 IF影响因子
开放是否OA
25 H-index
2001 创刊年份
Monthly 出版周期
English 出版语言

Discovery Medicine publishes novel, provocative ideas and research findings that challenge conventional notions about disease mechanisms, diagnosis, treatment, or any of the life sciences subjects. It publishes cutting-edge, reliable, and authoritative information in all branches of life sciences but primarily in the following areas: Novel therapies and diagnostics (approved or experimental); innovative ideas, research technologies, and translational research that will give rise to the next generation of new drugs and therapies; breakthrough understanding of mechanism of disease, biology, and physiology; and commercialization of biomedical discoveries pertaining to the development of new drugs, therapies, medical devices, and research technology.

[ 查看全部 ]

投稿咨询加急咨询

Discovery Medicine期刊信息

ISSN：1539-6509
出版语言：English
是否OA：开放
E-ISSN：1944-7930
出版地区：UNITED STATES
是否预警：否
出版商：Timonium, MD : Discovery Medicine
出版周期：Monthly
创刊时间：2001
开源占比：0
Gold OA文章占比：3.07%
OA被引用占比：0
出版国人文章占比：0.49
出版撤稿占比：0
研究类文章占比：81.38%

Discovery Medicine CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

5.4

0.807

0.749

学科类别	分区	排名	百分位
大类：Medicine 小类：General Medicine	Q1	29 / 529	94%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Discovery Medicine中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验	4区

Discovery Medicine JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	90 / 191	53.1
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q3	104 / 191	45.81

Discovery Medicine历年数据统计

影响因子

中科院分区

Discovery Medicine中国学者发文选摘

1、Oxaliplatin Combined With a PD-1 Inhibitor Synergistically Suppresses Gastric Cancer Growth via STEAP4-Mediated Ferroptosi
Author: Zou, Yuxiu; Dai, Fengxue; Feng, Li; Jia, Xiaoqiong

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 574-586. DOI: 10.24976/Discov.Med.202638205.47
2、CaMKIα-Driven Regulation of the AMPK/SIRT3 Pathway in Controlling Inflammatory Responses During Acute Lung Injur
Author: Zheng, Lina; Zhang, Bin; Zhao, Lingzhi; Zhang, Pengfei

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 468-481. DOI: 10.24976/Discov.Med.202638205.39
3、Independent Determinants of Diagnostic Delay in Female Patients With Axial Spondyloarthritis and Its Impact on 12-Month Disease Outcome
Author: Zhao, Hongcheng; Shen, Zhijia; Zhao, Jinyong; Yang, Guanyu; Zhang, Bohan; Huang, Xin; Wang, Wenhao; Yang, Huilin

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 482-490. DOI: 10.24976/Discov.Med.202638205.40
4、Computed Tomography-Based Radiomics Model for Predicting KIT Exon 11 Codons 557-558 Deletion Mutation in Gastrointestinal Stromal Tumor
Author: Zhang, Caijuan; Song, Qing; Wang, Jingyu; Dong, Dong; Xu, Weiling

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 587-596. DOI: 10.24976/Discov.Med.202638205.48
5、Advances in Understanding SIRT3's Relationship With Metabolic Diseases and Related Cardiovascular Complication
Author: Yu, Hai; Luo, Yi; Zhu, Ziyue; Yu, Tingting; Xu, Jing

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 357-367. DOI: 10.24976/Discov.Med.202638205.30
6、Propofol Ameliorates Neuroinflammation and Oxidative Stress in High-Fat Diet-Induced Rats via Regulation of the AMPK/mTOR Pathwa
Author: Ye, Siqi; Yan, Ke; Li, Lei; Xu, Qiao

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 443-452. DOI: 10.24976/Discov.Med.202638205.37
7、Systemic Immune-Inflammation Index as a Novel Biomarker for Differentiating Stage III and IV Periodontitis: A Propensity Score-Matched Retrospective Stud
Author: Wu, Yi; Zhang, Dandan

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 410-418. DOI: 10.24976/Discov.Med.202638205.34
8、Function and Mechanism of SLC38A5 in Retinoblastoma Developmen
Author: Wu, Chao; Deng, Yan; Xiong, Xiaoyan; Lu, Ying; Yin, Xiaolong

Journal: DISCOVERY MEDICINE. 2026; Vol. 38, Issue 205, pp. 491-504. DOI: 10.24976/Discov.Med.202638205.41